Targeting plasma cells in autoimmune diseases
- PMID: 15173204
- PMCID: PMC2211780
- DOI: 10.1084/jem.20040719
Targeting plasma cells in autoimmune diseases
Abstract
Antibodies specific for self-antigens mediate life-threatening pathology in several autoimmune diseases. Clearly the ability to target the plasma cells (PCs) producing the autoantibodies would be of great clinical benefit. Current immunosuppressive therapies are based on the premise that autoreactive PCs are short-lived and replenished from ongoing immune responses. However, recent results question this assumption and suggest that optimizing the treatment of severe autoimmune conditions will require a significant investment in elucidating the details of PC biology.
Figures
Similar articles
-
Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.J Exp Med. 2004 Jun 7;199(11):1577-84. doi: 10.1084/jem.20040168. Epub 2004 Jun 1. J Exp Med. 2004. PMID: 15173206 Free PMC article.
-
How to cope with pathogenic long-lived plasma cells in autoimmune diseases.Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii87-9. doi: 10.1136/ard.2008.098418. Ann Rheum Dis. 2008. PMID: 19022822 Review.
-
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.Nat Rev Rheumatol. 2011 Mar;7(3):170-8. doi: 10.1038/nrrheum.2011.1. Epub 2011 Feb 1. Nat Rev Rheumatol. 2011. PMID: 21283146 Review.
-
Long-lived plasma cells and their contribution to autoimmunity.Ann N Y Acad Sci. 2005 Jun;1050:124-33. doi: 10.1196/annals.1313.014. Ann N Y Acad Sci. 2005. PMID: 16014527 Review.
-
Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.Ann Rheum Dis. 2013 Dec;72(12):2011-7. doi: 10.1136/annrheumdis-2013-203455. Epub 2013 Oct 10. Ann Rheum Dis. 2013. PMID: 24114925
Cited by
-
Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus.Int J Mol Sci. 2019 Nov 29;20(23):6021. doi: 10.3390/ijms20236021. Int J Mol Sci. 2019. PMID: 31795353 Free PMC article. Review.
-
Targeting Plasma Cells with Proteasome Inhibitors: Principles from Primates.J Am Soc Nephrol. 2017 Jul;28(7):1951-1953. doi: 10.1681/ASN.2017040443. Epub 2017 Jun 7. J Am Soc Nephrol. 2017. PMID: 28592425 Free PMC article. No abstract available.
-
Memory B cells in transplantation.Transplantation. 2015 Jan;99(1):21-8. doi: 10.1097/TP.0000000000000545. Transplantation. 2015. PMID: 25525921 Free PMC article. Review.
-
CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3895-900. doi: 10.1073/pnas.0809736106. Epub 2009 Feb 19. Proc Natl Acad Sci U S A. 2009. PMID: 19228948 Free PMC article.
-
Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus.Autoimmunity. 2015 Mar;48(2):80-6. doi: 10.3109/08916934.2014.976627. Epub 2014 Oct 27. Autoimmunity. 2015. PMID: 25347333 Free PMC article.
References
-
- Drenkard, C., A.R. Villa, C. Garcia-Padilla, M.E. Perez-Vazquez, and D. Alarcon-Segovia. 1996. Remission of systematic lupus erythematosus. Medicine (Baltimore). 75:88–98. - PubMed
-
- Looney, R.J., J. Anolik, and I. Sanz. 2004. B cells as therapeutic targets for rheumatic diseases. Curr. Opin. Rheumatol. 16:180–185. - PubMed
-
- Zinkernagel, R.M. 1996. Immunology taught by viruses. Science. 271:173–178. - PubMed
-
- Manz, R.A., A. Thiel, and A. Radbruch. 1997. Lifetime of plasma cells in the bone marrow. Nature. 388:133–134. - PubMed
-
- Slifka, M.K., R. Antia, J.K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity. 8:363–372. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical